Johnson & Johnson (JNJ) Tax Rate (2009 - 2026)

Johnson & Johnson (JNJ) posted Tax Rate of 17.98% for Q2 2026, up 42.64% sequentially from 12.6% in Q1 2026, and up 328.0% YoY from 4.2% in Q2 2025.

Johnson & Johnson (JNJ) Tax Rate (2009 - 2026) Analysis & Trends

Johnson & Johnson has reported Tax Rate for 18 years, with the latest figure at 17.98% in Q2 2026.

Quarterly Tax Rate rose 328.0% year-over-year to 17.98% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 16.51% (down 63.0% YoY) and the FY2025 annual result came in at 17.73%, up 202.0% from the prior year.
Tax Rate advanced to 17.98% in Q2 2026 per JNJ's latest filing, from 12.6% in the prior quarter.
Over five years, Tax Rate peaked at 61.85% in Q2 2023 and troughed at 3.02% in Q4 2025.
A 5-year average of 19.13% and a median of 17.04% in 2022 frame the typical range for Tax Rate.
The sharpest annual moves came in 2023 and 2024: Tax Rate surged 4815 bps in 2023, then tumbled 4949 bps in 2024.
Over 5 years, Tax Rate stood at 16.67% in 2022, then declined by 14 bps to 14.38% in 2023, then declined by 18 bps to 11.73% in 2024, then tumbled by 126 bps to 3.02% in 2025, then soared by 695 bps to 17.98% in 2026.
According to Business Quant data, Tax Rate over the past three periods registered 17.98%, 12.6%, and 3.02% for Q2 2026, Q1 2026, and Q4 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Johnson & Johnson	645.88 Bn	625.12 Bn	17.26 Bn	17.98%
2	AbbVie	463.46 Bn	456.89 Bn	12.70 Bn	15.47%
3	Merck	367.92 Bn	360.78 Bn	12.21 Bn	-95.75%
4	Novartis Ag	297.71 Bn	290.02 Bn	11.24 Bn	23.71%
5	Astrazeneca	255.55 Bn	250.65 Bn	12.86 Bn	10.40%
6	Amgen	234.52 Bn	220.53 Bn	7.24 Bn	14.20%
7	Gilead Sciences	178.22 Bn	175.04 Bn	6.22 Bn	-2.36%
8	Pfizer	158.57 Bn	146.88 Bn	10.94 Bn	62.33%
9	Gsk	105.32 Bn	101.15 Bn	8.24 Bn	56.21%
10	Sanofi	54.20 Bn	46.82 Bn	10.79 Bn	-3.05%

Download Data